Register for real-time alerts, custom portfolio, and market movers
Period:
Draw Mode:
| Volume | 6,398 |
|
|||||
| News | - | ||||||
| Day High | 156.1701 | Low High |
|||||
| Day Low | 154.55 | ||||||
| Company Name | Etf Ticker Symbol | Market | Type |
|---|---|---|---|
| VanEck Biotech ETF | BBH | NASDAQ | Exchange Traded Fund |
| Price Change | Change Percent | Etf Price | Last Traded
|
|
|---|---|---|---|---|
| 0.82 | 0.53% | 155.59 | 20:00:00 |
| Open Price | Low Price | High Price | Close Price | Prev Close |
|---|---|---|---|---|
| 154.55 | 154.55 | 156.1701 | 155.59 | 154.77 |
| Trades | Volume | VWAP | Dollar Volume | Avg Volume | 52 Week Range |
|---|---|---|---|---|---|
| 198 | 6,398 | 155.81 | 996,851 | - | 142.51 - 171.045 |
| Last Trade Time | Type | Quantity | Etf Price | Currency |
|---|---|---|---|---|
| 16:05:08 | 1 | 152.86 | USD |
VanEck Biotech ETF Financials
| Market Cap | Shares in Issue | Float | Revenue | Profit/Loss | EPS | PE Ratio |
|---|---|---|---|---|---|---|
| 450.92M | 2.90M | - | 3.88M | 45.87M | 15.83 | 9.83 |
| Short Interest | Dividends Per Share | Dividend Yield | Ex-Div Date | Insider B/S | Insider % Owned |
|---|---|---|---|---|---|
| - | - | - | - |
News VanEck Biotech ETF
Loading Messages....
|
|
{{bbMessage.M_Alias}} {{bbMessage.MSG_Date}} {{bbMessage.HowLongAgo}} {{bbMessage.MSG_ID}} {{bbMessage.MSG_Subject}} |
Loading Messages....
BBH Historical
| Period | Open | High | Low | VWAP | Avg. Daily Vol | Change | % |
|---|---|---|---|---|---|---|---|
| 1 Week | 151.88 | 158.33 | 151.35 | 154.97 | 15,235 | 3.71 | 2.44% |
| 1 Month | 165.55 | 166.16 | 151.35 | 157.67 | 10,549 | -9.96 | -6.02% |
| 3 Months | 165.87 | 167.61 | 151.35 | 161.39 | 7,771 | -10.28 | -6.20% |
| 6 Months | 147.50 | 171.045 | 142.51 | 159.75 | 10,906 | 8.09 | 5.48% |
| 1 Year | 159.78 | 171.045 | 142.51 | 159.08 | 8,690 | -4.19 | -2.62% |
| 3 Years | 188.58 | 223.19 | 131.115 | 167.42 | 14,425 | -32.99 | -17.49% |
| 5 Years | 122.66 | 223.19 | 112.03 | 158.34 | 16,599 | 32.93 | 26.85% |
| The investment seeks to replicate as closely as possible, before fees and expenses, the price and yield performance of the MVIS US Listed Biotech 25 Index. The fund normally invests at least 80% of its total assets in securities that comprise the funds benchmark index. The Biotech Index includes common stocks and depositary receipts of U.S. exchange-listed companies in the biotechnology industry. Such companies may include medium-capitalization companies and foreign companies that are listed on a U.S. exchange. It is non-diversified. |
